Enzon Pharmaceuticals Inc
DUS:EZ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enzon Pharmaceuticals Inc
DUS:EZ1
|
US |
|
Western Gold Exploration Ltd
OTC:WGELF
|
CA |
|
J
|
Japan Prime Realty Investment Corp
F:58JA
|
JP |
|
T
|
Trinity Industries Inc
BMV:TRN
|
US |
|
P
|
Pro DV AG
XBER:PDA
|
DE |
|
D
|
Daishin Securities Co Ltd
KRX:003547
|
KR |
|
Aker Biomarine ASA
F:1PG
|
NO |
|
S
|
Sumitomo Bakelite Co Ltd
XMUN:SZ8
|
JP |
|
NEXE Innovations Inc
F:NX5
|
CA |
|
Ensurge Micropower ASA
F:B7X1
|
NO |
|
5Th Planet Games A/S
F:2HG1
|
DK |
|
Menicon Co Ltd
F:5FR
|
JP |
|
Mainz Biomed NV
F:4TO
|
DE |
|
Embraer SA
BOVESPA:EMBR3
|
BR |
|
R
|
Riber SA
XBER:RI7
|
FR |
|
Deutsche Pfandbriefbank AG
OTC:PBBGF
|
DE |
|
D
|
Domiki Kritis SA
F:F9P
|
GR |
|
N
|
N Leventeris SA
ATHEX:LEBEP
|
GR |
|
CytoMed Therapeutics Ltd
F:F98
|
SG |
|
A
|
AmmPower Corp
OTC:AMMPF
|
CA |
Bankruptcy Probability
Enzon Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Enzon Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
59.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
469.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
140.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Enzon Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Enzon Pharmaceuticals Inc has total debt of 130.8m USD. This includes both short-term (51.1m USD) and long-term (79.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
